These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 7236899

  • 1. Clinical objectives and normal tissue responses in combined chemotherapy and radiotherapy.
    Peckham MJ, Collis CH.
    Bull Cancer; 1981; 68(2):132-41. PubMed ID: 7236899
    [Abstract] [Full Text] [Related]

  • 2. [Late complications in patients cured of neoplasms in childhood].
    Armata J, Balwierz W.
    Przegl Lek; 1992; 49(3):69-72. PubMed ID: 1438897
    [Abstract] [Full Text] [Related]

  • 3. Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis.
    Marini P, Schmid A, Jendrossek V, Faltin H, Daniel PT, Budach W, Belka C.
    BMC Cancer; 2005 Jan 14; 5():5. PubMed ID: 15651986
    [Abstract] [Full Text] [Related]

  • 4. Complications of Combined Radiotherapy and Chemotherapy.
    von der Maase H.
    Semin Radiat Oncol; 1994 Apr 14; 4(2):81-94. PubMed ID: 10717094
    [Abstract] [Full Text] [Related]

  • 5. EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms.
    Baumann M, Krause M, Dikomey E, Dittmann K, Dörr W, Kasten-Pisula U, Rodemann HP.
    Radiother Oncol; 2007 Jun 14; 83(3):238-48. PubMed ID: 17502118
    [Abstract] [Full Text] [Related]

  • 6. [Combined treatment with radiotherapy and chemotherapy (author's transl)].
    Tubiana M.
    Bull Cancer; 1981 Jun 14; 68(2):109-15. PubMed ID: 6263383
    [Abstract] [Full Text] [Related]

  • 7. Clinical experience with misonidazole.
    Dische S, Saunders MI.
    Br J Cancer Suppl; 1978 Jun 14; 3():311-3. PubMed ID: 277252
    [Abstract] [Full Text] [Related]

  • 8. Induction chemotherapy: to downgrade aggressive cancers to improve curability by surgery and/or radiotherapy.
    Stephens FO.
    Eur J Surg Oncol; 2001 Nov 14; 27(7):672-88. PubMed ID: 11669597
    [Abstract] [Full Text] [Related]

  • 9. New concepts for phase I trials: evaluating new drugs combined with radiation therapy.
    Deutsch E, Soria JC, Armand JP.
    Nat Clin Pract Oncol; 2005 Sep 14; 2(9):456-65. PubMed ID: 16264990
    [Abstract] [Full Text] [Related]

  • 10. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD, Flickinger JC, Larson D.
    Oncologist; 1997 Sep 14; 2(1):59-61. PubMed ID: 10388030
    [Abstract] [Full Text] [Related]

  • 11. Early and late radiation-induced skin alterations. Part I: Mechanisms of skin changes.
    Sitton E.
    Oncol Nurs Forum; 1992 Jun 14; 19(5):801-7. PubMed ID: 1608843
    [Abstract] [Full Text] [Related]

  • 12. Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues.
    Phillips TL, Fu KK.
    Cancer; 1976 Feb 14; 37(2 Suppl):1186-1200. PubMed ID: 766958
    [Abstract] [Full Text] [Related]

  • 13. Radiation therapy toxicity to the skin.
    Fitzgerald TJ, Jodoin MB, Tillman G, Aronowitz J, Pieters R, Balducci S, Meyer J, Cicchetti MG, Kadish S, McCauley S, Sawicka J, Urie M, Lo YC, Mayo C, Ulin K, Ding L, Britton M, Huang J, Arous E.
    Dermatol Clin; 2008 Jan 14; 26(1):161-72, ix. PubMed ID: 18023776
    [Abstract] [Full Text] [Related]

  • 14. Complications of oncologic therapy in the abdomen and pelvis: a review.
    Ganeshan DM, Salem U, Viswanathan C, Balachandran A, Garg N, Silverman P, Bhosale P.
    Abdom Imaging; 2013 Feb 14; 38(1):1-21. PubMed ID: 22644726
    [Abstract] [Full Text] [Related]

  • 15. Anticancer Drug Development: The Way Forward.
    Connors T.
    Oncologist; 1996 Feb 14; 1(3):180-181. PubMed ID: 10387985
    [Abstract] [Full Text] [Related]

  • 16. Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins.
    Lee TK, Stupans I.
    J Pharm Pharmacol; 2002 Nov 14; 54(11):1435-45. PubMed ID: 12495545
    [Abstract] [Full Text] [Related]

  • 17. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 14; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 18. Gastrointestinal workshop.
    Ketcham A, Withers HR.
    Cancer Clin Trials; 1981 Dec 14; 4 Suppl():15-8. PubMed ID: 7307222
    [No Abstract] [Full Text] [Related]

  • 19. Future development of amifostine as a radioprotectant.
    Werner-Wasik M.
    Semin Oncol; 1999 Apr 14; 26(2 Suppl 7):129-34. PubMed ID: 10348272
    [Abstract] [Full Text] [Related]

  • 20. Dichotomic actions of glutamine in host versus tumour: an emerging concept.
    Belabed L, Darmon P, Pichard C.
    Curr Opin Clin Nutr Metab Care; 2009 Jul 14; 12(4):372-7. PubMed ID: 19465847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.